MP10: Kidney Cancer: Advanced (including Drug Therapy) I
221C
Poster and Podium Sessions
Oncology: Adrenal/Kidney
Information
Continuing Medical Education
CME
Friday, May 3
MP10-01: CD73 Blockade Potentiates FH-cGAS-STING Axis in the microenvironment of Renal Cell Carcinoma
Friday, May 3, 2024 9:30 AM to 11:30 AM
221C
MP10-02: A novel therapeutic target SCG2 might cooperate with HIF1α in TKI-resistant renal cell carcinoma
Friday, May 3, 2024 9:30 AM to 11:30 AM
221C
MP10-03: Analyses of tumor microenvironment changes of clear cell renal cell carcinoma with inferior vena cava thrombus following neoadjuvant anti-PD-1 and tyrosine kinase inhibitor combination therapy
Friday, May 3, 2024 9:30 AM to 11:30 AM
221C
MP10-04: High expression of cancer-derived IgG is associated with poor survival in metastatic clear cell renal cell carcinoma
Friday, May 3, 2024 9:30 AM to 11:30 AM
221C
MP10-05: Multigene assays to predict malignancy and drug efficacy in renal cell carcinoma and pan-cancer: Development and dual external validation
Friday, May 3, 2024 9:30 AM to 11:30 AM
221C
MP10-06: Elevated eosinophils before 2 course treatment may be a universal biomarker for immune-related adverse events induced by common to different immune checkpoint inhibitor and cancer types including to urological cancer
Friday, May 3, 2024 9:30 AM to 11:30 AM
221C
MP10-07: Comprehensive Evaluation of Response to Immune Checkpoint Blockade in Primary Tumor: Radiographic and Radiomic Features Predict Pathologic Response in Primary Tumor
Friday, May 3, 2024 9:30 AM to 11:30 AM
221C
MP10-08: Sarcomatoid dedifferentiation as a predictor of overall mortality in surgically treated metastatic renal cell carcinoma
Friday, May 3, 2024 9:30 AM to 11:30 AM
221C
MP10-09: Differential Impact of Positive Surgical Margin in high-risk localized Renal Cell Carcinoma after adjuvant and neoadjuvant systemic therapy: A Multicenter Analysis.
Friday, May 3, 2024 9:30 AM to 11:30 AM
221C
MP10-10: Prognostic Significance of the Site of Invasion in pT3a Renal Cell Carcinoma
Friday, May 3, 2024 9:30 AM to 11:30 AM
221C
MP10-11: A Propensity Score-Matched Analysis of Outcomes of Neoadjuvant and Adjuvant Systemic Therapy in High-Risk Localized Renal Cell Carcinoma: Impact of Timing of Therapy and Positive Margin
Friday, May 3, 2024 9:30 AM to 11:30 AM
221C
MP10-12: The efficacy and safety of neoadjuvant immunotherapy plus TKIs therapy in patients with renal cell carcinoma and inferior vena cava thrombus and its impact on robot-assisted surgical outcomes
Friday, May 3, 2024 9:30 AM to 11:30 AM
221C
MP10-13: Safety and Efficacy of Surgery in Metastatic and Non-Metastatic Renal Cell Carcinoma with Supradiaphragmatic Tumor Thrombus Involving Cardiac Procedures
Friday, May 3, 2024 9:30 AM to 11:30 AM
221C
MP10-14: Contemporary Analysis of Oncological Outcomes of Radical Nephrectomy with Venous Thrombectomy for Renal Cell Carcinoma
Friday, May 3, 2024 9:30 AM to 11:30 AM
221C
MP10-15: USING ARTIFICIAL INTELLIGENCE TO CHARACTERIZE BODY COMPOSITION IN PATIENTS UNDERGOING CYTOREDUCTIVE NEPHRECTOMY
Friday, May 3, 2024 9:30 AM to 11:30 AM
221C
MP10-16: Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival in Patients Following Cytoreductive Nephrectomy
Friday, May 3, 2024 9:30 AM to 11:30 AM
221C
MP10-17: Impact of corticosteroid administration on treatment effectiveness in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitor-based combination therapy
Friday, May 3, 2024 9:30 AM to 11:30 AM
221C
MP10-18: ANTICOAGULANT MEDICATIONS FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS IN NEPHRECTOMIES
Friday, May 3, 2024 9:30 AM to 11:30 AM
221C
MP10-19: Management of Chronic Pain and Overall Mortality in Metastatic Renal Cell Carcinoma: A Multicenter Investigation from a Large Global Health Research Network (TriNetX)
Friday, May 3, 2024 9:30 AM to 11:30 AM
221C
MP10-20: Adjuvant Targeted Drug Therapy in Preventing Recurrence of High-Risk Renal Cancer Post-Surgery:A Systemic Review and Meta Analysis
Friday, May 3, 2024 9:30 AM to 11:30 AM
221C